CBIO vs FSLR · rev $1.0M vs P/E 16, rev $2.10B
Crescent Biopharma, Inc. (CBIO) versus First Solar Inc (FSLR) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
First Solar Inc (FSLR) is a solar company listed on NASDAQ. It is led by Mark R. Widmar.
Latest reported CBIO revenue for 2026-06-30 was $1.0M. Net income was -$48.1M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. CBIO currently screens at market cap $491.3M.
Latest reported FSLR revenue for 2026-06-30 was $2.10B. Net income was $769.2M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
CBIO currently screens at market cap $491.3M. FSLR currently screens at market cap $27.38B and trailing P/E 16.4.
Not investment advice. Open the CBIO and FSLR stock pages for the full models.
Not investment advice.